Supriya Lifesciences Ltd. is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs). It has a niche product offering of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and antiallergic.Don't have a Tradeplus account? Sign up
The company's pharmaceutical business is organized into domestic and export sales with distribution spanned across 86 countries across Europe, Latin America, Asia, and North America. In Fiscals 2019, 2020, and 2021, sales from exports accounted for 70.96%, 71.85%, and 77.47% of the revenue of operations.The Rs. 700 crore public offering of Supriya Lifesciences comprises a fresh issue of equity shares aggregating up to Rs. 200 crores and an offer for sale of equity shares aggregating up to Rs. 500 crores from selling shareholders. Read more
|Financial Year Ended||Revenue (₹ Millions)||Profit After Tax (₹ Millions)||EPS (₹)|
You can apply for the Supriya Lifescience Limited IPO using any supported UPI app by following two steps:
On acceptance of the mandate, the bid amount will get blocked in your bank account.
I'm a cool paragraph that lives inside of an even cooler modal. Wins!
You will receive an OTP on your mobile